Kyndryl Faces Securities Class Action Lawsuit
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 11 2026
0mins
Should l Buy KD?
Source: Businesswire
- Lawsuit Background: Kyndryl Holdings, Inc. has been hit with a class action lawsuit for allegedly issuing false financial reports between August 7, 2024, and February 9, 2026, with accusations against its executives for violating the Securities Exchange Act of 1934, potentially leading to significant investor losses.
- Financial Misstatement Allegations: The lawsuit claims that Kyndryl's financial statements during this period were materially misstated and that the company lacked adequate internal controls, resulting in its inability to timely file its Quarterly Report for the quarter ended December 31, 2025, which could damage its reputation and investor confidence.
- Executive Departures: Kyndryl announced the immediate departure of CFO David Wyshner and General Counsel Edward Sebold during the lawsuit period, along with a role change for Senior Vice President Vineet Khurana, raising further concerns about the company's governance and stability in the eyes of investors.
- Stock Price Plunge: Following the lawsuit announcement, Kyndryl's stock price plummeted by 55%, indicating severe market concerns regarding the company's financial health, which may adversely affect its future financing and business growth prospects.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy KD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on KD
Wall Street analysts forecast KD stock price to rise
4 Analyst Rating
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 13.510
Low
28.00
Averages
33.25
High
40.00
Current: 13.510
Low
28.00
Averages
33.25
High
40.00
About KD
Kyndryl Holdings, Inc. is a provider of mission-critical enterprise technology services offering advisory, implementation and managed service capabilities to customers in more than 60 countries. The Company designs, builds, manages and modernizes complex information systems around the world. Its segments include United States, Japan, Principal Markets and Strategic Markets. It offers services across domains, such as cloud services, core enterprise and zCloud services, applications, data and artificial intelligence (AI) services, digital workplace services, security and resiliency services and network and edge services. Its advisory and implementation services are branded as Kyndryl Consult. It provides end-to-end enterprise data services, including data transformation, data architecture and management, data governance and compliance and data migration. It provides comprehensive enterprise cybersecurity services for chief information security officers (CISOs) and chief risk officers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Kyndryl Faces Securities Class Action Lawsuit
- Lawsuit Deadline: ClaimsFiler reminds Kyndryl investors that lead plaintiff applications must be filed by April 13, 2026, for shares purchased between August 7, 2024, and February 9, 2026, highlighting investor concerns over potential legal risks.
- Financial Reporting Delay: On February 9, 2026, Kyndryl disclosed its inability to timely file its Form 10-Q for the quarter ended December 31, 2025, anticipating reporting material weaknesses in internal controls, which may erode investor confidence in the company's financial transparency.
- Stock Price Plunge: Following the lawsuit announcement, Kyndryl's stock price plummeted by $12.90, a 55% drop, closing at $10.59, reflecting severe market concerns regarding the company's governance and financial health.
- Executive Departures: The departure of Kyndryl's CFO and General Counsel exacerbates investor unease, potentially impacting strategic decision-making and future growth, while complicating the ongoing legal proceedings.
See More
Kyndryl Faces Lawsuit After Financial Reporting Failures
- Control Failures: Kyndryl's amended reports filed on February 17, 2026, revealed ineffective internal controls over financial reporting as of March, June, and September 2025, leading to a dramatic 55% drop in share price on February 9, 2026, as investor confidence plummeted.
- Executive Departures: The immediate resignations of CFO David Wyshner and General Counsel Edward Sebold on February 5, 2026, have intensified concerns regarding corporate governance and further eroded shareholder trust in the company's leadership.
- SEC Scrutiny Intensifies: Kyndryl has received document requests from the SEC related to cash management practices under review by its Audit Committee, highlighting significant transparency issues that could lead to broader legal ramifications for the company.
- Class Action Lawsuit: Following the stock plunge, Hagens Berman has initiated a securities class action lawsuit against Kyndryl, seeking to represent investors who acquired securities between August 7, 2024, and February 9, 2026, which is likely to have profound implications for the company's future financial health.
See More
Kyndryl and Others Face Class Action Lawsuits
- Kyndryl Lawsuit Overview: Kyndryl Holdings, Inc. (NYSE:KD) faces a class action lawsuit for materially misstated financial statements during the period from August 7, 2024, to February 9, 2026, with a lead plaintiff deadline of April 13, 2026, potentially impacting the company's reputation and stock volatility.
- PayPal Legal Issues: PayPal Holdings, Inc. (NASDAQ:PYPL) is accused in a class action lawsuit from February 25, 2025, to February 2, 2026, of failing to effectively execute its branded checkout initiatives, with a lead plaintiff deadline of April 20, 2026, which could affect its market competitiveness and investor confidence.
- NuScale Risk Disclosure: NuScale Power Corporation (NYSE:SMR) faces legal challenges in a class action lawsuit from May 13, 2025, to November 6, 2025, for not disclosing risks associated with its partnership with ENTRA1, with a lead plaintiff deadline of April 20, 2026, potentially hindering its commercialization strategy.
- Corcept Regulatory Challenges: Corcept Therapeutics Incorporated (NASDAQ:CORT) is involved in a class action lawsuit from October 31, 2024, to January 30, 2026, due to FDA concerns regarding the adequacy of its drug effectiveness assessment, with a lead plaintiff deadline of April 21, 2026, which may impact its drug approval process and company outlook.
See More
Kyndryl Faces Class Action Lawsuit Reminder for Investors
- Class Action Notification: The Schall Law Firm reminds investors of a class action lawsuit against Kyndryl Holdings, Inc. for violations of the Securities Exchange Act, concerning securities purchased between August 7, 2024, and February 9, 2026, with a deadline to contact the firm by April 13, 2026, to participate.
- Misleading Financial Statements: The complaint alleges that Kyndryl made false and misleading statements, materially misstating its financial reports, which resulted in significant investor losses when the truth emerged, highlighting serious deficiencies in the company's internal controls over financial reporting.
- Lack of Legal Representation: The class action has not yet been certified, meaning investors are not represented by an attorney until certification occurs; those who choose not to act will remain absent class members and may miss the opportunity to recover losses.
- Investor Rights Advocacy: The Schall Law Firm specializes in securities class action lawsuits and encourages affected investors to reach out for discussions about their rights, demonstrating the firm's commitment to providing legal support for investors worldwide.
See More
Faruqi & Faruqi Encourages Kyndryl Investors to Reach Out
- Legal Investigation: Faruq & Faruqi LLP is investigating potential claims against Kyndryl Holdings, Inc., specifically targeting investors who purchased securities between August 7, 2024, and February 9, 2026, indicating concerns over the company's financial health.
- Investor Contact Information: Securities Litigation Partner Josh Wilson encourages affected investors to reach out directly at 877-247-4292 or 212-983-9330 (Ext. 1310), aiming to assist them in understanding their legal rights and options.
- Class Action Deadline: The firm reminds investors that the deadline to seek the role of lead plaintiff in the federal securities class action against Kyndryl is April 13, 2026, which could significantly impact investors' ability to file claims.
- Potential Market Impact: The ongoing legal investigation may exert downward pressure on Kyndryl's stock price, prompting investors to closely monitor developments to adjust their investment strategies accordingly.
See More
Solas Capital Initiates New Position in Kyndryl
- New Position Disclosure: On February 17, 2026, Solas Capital Management disclosed a new position in Kyndryl by acquiring 407,634 shares valued at $10.83 million, reflecting both confidence in the company and concerns over market volatility.
- Asset Allocation Change: This acquisition represents 6.14% of Solas Capital's reportable assets under management, indicating Kyndryl's significance in the investment portfolio, despite its stock price plummeting by 67.5% over the past year.
- Financial Performance Overview: Kyndryl's latest financial metrics reveal a trailing twelve-month revenue of $15.12 billion and a net income of $249 million, with a market capitalization of $3.06 billion, highlighting ongoing challenges in the IT infrastructure services sector, particularly in its partnership with IBM.
- Uncertain Market Outlook: While Solas Capital's investment in Kyndryl has garnered attention, the company's delay in filing its 10-Q and the resignation of key executives have led investors to adopt a cautious stance regarding its future sales cycles and market performance, potentially impacting further stock price volatility.
See More
Kyndryl Faces Securities Class Action Lawsuit
- Lawsuit Deadline: ClaimsFiler reminds Kyndryl investors that lead plaintiff applications must be filed by April 13, 2026, for shares purchased between August 7, 2024, and February 9, 2026, highlighting investor concerns over potential legal risks.
- Financial Reporting Delay: On February 9, 2026, Kyndryl disclosed its inability to timely file its Form 10-Q for the quarter ended December 31, 2025, anticipating reporting material weaknesses in internal controls, which may erode investor confidence in the company's financial transparency.
- Stock Price Plunge: Following the lawsuit announcement, Kyndryl's stock price plummeted by $12.90, a 55% drop, closing at $10.59, reflecting severe market concerns regarding the company's governance and financial health.
- Executive Departures: The departure of Kyndryl's CFO and General Counsel exacerbates investor unease, potentially impacting strategic decision-making and future growth, while complicating the ongoing legal proceedings.
See More
Kyndryl Faces Lawsuit After Financial Reporting Failures
- Control Failures: Kyndryl's amended reports filed on February 17, 2026, revealed ineffective internal controls over financial reporting as of March, June, and September 2025, leading to a dramatic 55% drop in share price on February 9, 2026, as investor confidence plummeted.
- Executive Departures: The immediate resignations of CFO David Wyshner and General Counsel Edward Sebold on February 5, 2026, have intensified concerns regarding corporate governance and further eroded shareholder trust in the company's leadership.
- SEC Scrutiny Intensifies: Kyndryl has received document requests from the SEC related to cash management practices under review by its Audit Committee, highlighting significant transparency issues that could lead to broader legal ramifications for the company.
- Class Action Lawsuit: Following the stock plunge, Hagens Berman has initiated a securities class action lawsuit against Kyndryl, seeking to represent investors who acquired securities between August 7, 2024, and February 9, 2026, which is likely to have profound implications for the company's future financial health.
See More
Kyndryl and Others Face Class Action Lawsuits
- Kyndryl Lawsuit Overview: Kyndryl Holdings, Inc. (NYSE:KD) faces a class action lawsuit for materially misstated financial statements during the period from August 7, 2024, to February 9, 2026, with a lead plaintiff deadline of April 13, 2026, potentially impacting the company's reputation and stock volatility.
- PayPal Legal Issues: PayPal Holdings, Inc. (NASDAQ:PYPL) is accused in a class action lawsuit from February 25, 2025, to February 2, 2026, of failing to effectively execute its branded checkout initiatives, with a lead plaintiff deadline of April 20, 2026, which could affect its market competitiveness and investor confidence.
- NuScale Risk Disclosure: NuScale Power Corporation (NYSE:SMR) faces legal challenges in a class action lawsuit from May 13, 2025, to November 6, 2025, for not disclosing risks associated with its partnership with ENTRA1, with a lead plaintiff deadline of April 20, 2026, potentially hindering its commercialization strategy.
- Corcept Regulatory Challenges: Corcept Therapeutics Incorporated (NASDAQ:CORT) is involved in a class action lawsuit from October 31, 2024, to January 30, 2026, due to FDA concerns regarding the adequacy of its drug effectiveness assessment, with a lead plaintiff deadline of April 21, 2026, which may impact its drug approval process and company outlook.
See More
Kyndryl Faces Class Action Lawsuit Reminder for Investors
- Class Action Notification: The Schall Law Firm reminds investors of a class action lawsuit against Kyndryl Holdings, Inc. for violations of the Securities Exchange Act, concerning securities purchased between August 7, 2024, and February 9, 2026, with a deadline to contact the firm by April 13, 2026, to participate.
- Misleading Financial Statements: The complaint alleges that Kyndryl made false and misleading statements, materially misstating its financial reports, which resulted in significant investor losses when the truth emerged, highlighting serious deficiencies in the company's internal controls over financial reporting.
- Lack of Legal Representation: The class action has not yet been certified, meaning investors are not represented by an attorney until certification occurs; those who choose not to act will remain absent class members and may miss the opportunity to recover losses.
- Investor Rights Advocacy: The Schall Law Firm specializes in securities class action lawsuits and encourages affected investors to reach out for discussions about their rights, demonstrating the firm's commitment to providing legal support for investors worldwide.
See More
Faruqi & Faruqi Encourages Kyndryl Investors to Reach Out
- Legal Investigation: Faruq & Faruqi LLP is investigating potential claims against Kyndryl Holdings, Inc., specifically targeting investors who purchased securities between August 7, 2024, and February 9, 2026, indicating concerns over the company's financial health.
- Investor Contact Information: Securities Litigation Partner Josh Wilson encourages affected investors to reach out directly at 877-247-4292 or 212-983-9330 (Ext. 1310), aiming to assist them in understanding their legal rights and options.
- Class Action Deadline: The firm reminds investors that the deadline to seek the role of lead plaintiff in the federal securities class action against Kyndryl is April 13, 2026, which could significantly impact investors' ability to file claims.
- Potential Market Impact: The ongoing legal investigation may exert downward pressure on Kyndryl's stock price, prompting investors to closely monitor developments to adjust their investment strategies accordingly.
See More
Solas Capital Initiates New Position in Kyndryl
- New Position Disclosure: On February 17, 2026, Solas Capital Management disclosed a new position in Kyndryl by acquiring 407,634 shares valued at $10.83 million, reflecting both confidence in the company and concerns over market volatility.
- Asset Allocation Change: This acquisition represents 6.14% of Solas Capital's reportable assets under management, indicating Kyndryl's significance in the investment portfolio, despite its stock price plummeting by 67.5% over the past year.
- Financial Performance Overview: Kyndryl's latest financial metrics reveal a trailing twelve-month revenue of $15.12 billion and a net income of $249 million, with a market capitalization of $3.06 billion, highlighting ongoing challenges in the IT infrastructure services sector, particularly in its partnership with IBM.
- Uncertain Market Outlook: While Solas Capital's investment in Kyndryl has garnered attention, the company's delay in filing its 10-Q and the resignation of key executives have led investors to adopt a cautious stance regarding its future sales cycles and market performance, potentially impacting further stock price volatility.
See More
